Dr. Schnabel on Predicting Breast Cancer by Atypia Type

Video

Dr. Freya Schnabel from NYU School of Medicine on Predicting Breast Cancer by Atypia Type

Freya R. Schnabel, MD, Professor of Surgery, NYU School of Medicine, summarizes information presented at the 2011 San Antonio Breast Cancer Symposium that discussed the risk of developing breast cancer in women with atypical lesions.

Atypical ductal and lobular hyperplasia and lobular carcinoma in situ are risk factors for developing breast cancer. The degree of risk varies depending on the atypia type.

All varieties of lesions increased a women's risk for breast by similar amounts. On average cancer began developing 4 years after the lesions were detected, the 10-year cancer risk varied from 14% to 20%. Additionally, the majority of cancers occurred ipsilaterally for all atypia types combined.

This information challenges previously held assumptions on breast cancer risk factors. It was previously believed that cancer should develop equally without regards to laterality. However, the data suggests that more cancer developed in the same breast as the lesions than contralateral.

Related Videos
Jeremy M. Pantin, MD, clinical director, Adult Transplant and Cellular Therapy Program, TriStar Centennial Medical Center, bone marrow transplant physician, Sarah Cannon Research Institute
Maria Hafez, MD, assistant professor, breast and sarcoma medical oncologist, director, Clinical Breast Cancer Research, Sidney Kimmel Medical College, Thomas Jefferson University
Zeynep Eroglu, MD
Sundar Jagannath, MBBS, director, Center of Excellence for Multiple Myeloma, professor of medicine (hematology and medical oncology), The Tisch Cancer Institute, Mount Sinai
Akriti Jain, MD
Raj Singh, MD
Gottfried Konecny, MD
Karim Chamie, MD, associate professor, urology, the University of California, Los Angeles
Mike Lattanzi, MD, medical oncologist, Texas Oncology
Ramez N. Eskander, MD